PER2 and central nervous system cancer: The authors suggest that since PER2 targets the Wnt/β-catenin signaling pathway in GSCs, the downregulation of critical proteins involved in the invasiveness and stemness of GSCs, such as Wnt7b, β-catenin, MMP2, MMP9, and c-Myc, may explain the tumor suppressive role of PER2 in gliomas [233].